Identification of a putative Gag binding site critical for feline immunodeficiency virus (FIV) genomic RNA packaging.

Feline immunodeficiency virus (FIV) RNA packaging signal (ψ) RNA secondary structure Retroviruses hSHAPE

Journal

RNA (New York, N.Y.)
ISSN: 1469-9001
Titre abrégé: RNA
Pays: United States
ID NLM: 9509184

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 15 09 2023
accepted: 20 10 2023
medline: 2 11 2023
pubmed: 2 11 2023
entrez: 1 11 2023
Statut: aheadofprint

Résumé

The retroviral Gag precursor plays a central role in the selection and packaging of viral genomic RNA (gRNA) by binding to virus-specific packaging signal(s) (psi or ψ). Previously, we have mapped the FIV ψ to two discontinuous regions within the 5' end of the gRNA that assumes a higher order structure harboring several structural motifs. To better define the region and structural elements important for gRNA packaging, we methodically investigated these FIV ψ sequences employing genetic, biochemical, and structure-function relationship approaches. Our mutational analysis revealed that the unpaired U85CUG88 stretch within FIV ψ is crucial for gRNA encapsidation into nascent virions. High-throughput Selective 2' Hydroxyl Acylation analyzed by Primer Extension (hSHAPE) performed on wild type and mutant FIV ψ sequences with substitutions in the U85CUG88 stretch revealed that these mutations had limited structural impact and maintained nucleotides 80 to 92 unpaired, as in the wild type structure. Since these mutations dramatically affected packaging, our data suggests that the single-stranded U85CUG88 sequence is important during FIV RNA packaging. Filter binding assays performed using purified FIV Pr50Gag on wild type and mutant U85CUG88 ψ RNAs led to reduced levels of Pr50Gag binding to mutant U85CUG88 ψ RNAs, indicating that the U85CUG88 stretch is crucial for ψ RNA-Pr50Gag interactions. Delineating sequences important for FIV gRNA encapsidation should enhance our understanding of both gRNA packaging and virion assembly, making them potential targets for novel retroviral therapeutic interventions, as well as development of FIV-based vectors for human gene therapy.

Identifiants

pubmed: 37914398
pii: rna.079840.123
doi: 10.1261/rna.079840.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Cold Spring Harbor Laboratory Press for the RNA Society.

Auteurs

Anjana Krishnan (A)

United Arab Emirates University, College of Medicine and Health Sciences.

Lizna M Ali (LM)

United Arab Emirates University, College of Medicine and Health Sciences.

Suresha G Prabhu (SG)

United Arab Emirates University, College of Medicine and Health Sciences.

Vineeta N Pillai (VN)

United Arab Emirates University, College of Medicine and Health Sciences.

Akhil Chameettachal (A)

United Arab Emirates University, College of Medicine and Health Sciences.

Valerie Vivet-Boudou (V)

University of Strasbourg, CNRS.

Serena Bernacchi (S)

University of Strasbourg, CNRS.

Farah Mustafa (F)

United Arab Emirates University, College of Medicine and Health Sciences.

Roland Marquet (R)

University of Strasbourg, CNRS.

Tahir A Rizvi (TA)

United Arab Emirates University, College of Medicine and Health Sciences; tarizvi@uaeu.ac.ae.

Classifications MeSH